Luis B Marrero, MD | |
23 Kennedy St, Suite 302, Bradford, PA 16701-2005 | |
(814) 362-9804 | |
(814) 362-6571 |
Full Name | Luis B Marrero |
---|---|
Gender | Male |
Speciality | Internal Medicine - Gastroenterology |
Location | 23 Kennedy St, Bradford, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518907880 | NPI | - | NPPES |
1011278940001 | Other | MEDICAL ASST | |
197611 | Other | BLUESHIELD | |
1624770 | Other | HIGHMARK GROUP KEYSTONE | |
MD035910E | Other | PA LICENSE | |
352438 | Other | HEALTH AMERICA | |
20118561300 | Other | OH | BUREAU OF WIC GROUP |
0010502400004 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | MD035910E (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Luis B Marrero, MD 7 Acee Drive, Natrona Heights, PA 15065 Ph: (800) 223-5544 | Luis B Marrero, MD 23 Kennedy St, Suite 302, Bradford, PA 16701-2005 Ph: (814) 362-9804 |
News Archive
MIT engineers have designed tiny robots that can help drug-delivery nanoparticles push their way out of the bloodstream and into a tumor or another disease site.
Lupus Research Institute-funded researcher Betty Tsao, PhD, at the University of California Los Angeles has discovered that humans-males in particular-with a variant form of the immune receptor gene "Toll Like Receptor 7 (TLR7)" are at increased risk of developing the autoimmune disease systemic lupus erythematosus (lupus). This breakthrough finding offers renewed hope for developing more targeted treatments.
Researchers have reported the first clinical evidence that gene therapy reduces symptoms in patients with rheumatoid arthritis, an important milestone for this promising treatment which has endured a sometimes turbulent past.
Cardiovascular disease remains the number one cause of death. It is well known that being physically fit is associated with lower risk of disease. One factor associated with higher risk of cardiovascular disease is having a low maximal heart rate.
Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it will be presenting detailed results from its recently completed Phase 2a FDA trial on ORMD-0801, its orally ingestible insulin capsule at the 2014 GTC Diabetes Summit taking place from April 23-25, 2014, in Boston, Massachusetts, USA.
› Verified 3 days ago
Dr. Anita J. Herbert, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 116 Interstate Pkwy, Occ. Health Systems, Bradford, PA 16701 Phone: 814-368-2000 | |
Dr. Kamran Saleh, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 24 W Washington St, Bradford, PA 16701 Phone: 814-368-1000 | |
Steven Clarke Herrmann, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 116 Interstate Pkwy, Bradford, PA 16701 Phone: 814-368-8720 | |
Dr. Paul Bruce Kirsch, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2 N Center St, Bradford, PA 16701 Phone: 814-362-2625 | |
Yahya Fadl, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 116 Interstate Pkwy, Bradford, PA 16701 Phone: 814-368-3123 | |
Peter Vaccaro, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 24 W Washington St, Bradford, PA 16701 Phone: 814-368-1000 |